Skip to main content

Table 2 Rotavirus-related events or costs with and without rotavirus vaccine and averted outcomes with vaccination, (lower limit, upper limit)

From: Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study

 

Without vaccine

With RI

Averted by vaccine

% reduction

With SIA

Averted by vaccine

% reduction

No. of events

       

 Deaths

3,864

2,956 (1,478-4,434)

908 (454–1,362)

23.5

3,504 (1,752-5,257)

359 (180–539)

9.3

 Cases

606,917

499,251 (374,438-624,064)

107,665 (80,749-134,582)

17.7

564,309 (423,232-705,386)

42,608 (31,956-53,260)

7.0

 Receive care

100,961

81,203 (60,902-101,504)

19,758 (14,818-24,697)

19.6

93,142 (69,857-116,428)

7,819 (5,864-9,774)

7.7

 Number of DALYs

197,683

151,308 (76,236-226,381)

46,375 (23,313-69,437)

23.5

179,331 (90,323-268,338)

18,353 (9,226-27,479)

9.3

 DALYs averted per 1000 children

  

109 (55–163)

  

43 (22–65)

 

Medical treatment costs (US$)

322,618

258,825 (194,119-323,532)

63,793 (36,067-79,741)

19.8

297,372 (223,029-371,716)

25,246 (18,934-31,557)

7.8

Vaccination program costs (US$)

--

309,458 (126,309-726,279)

--

--

715,713 (261,292-942,923)

--

--

Net costs (medical plus vaccination campaign, US$)

--

568,283 (385,135-985,104)

--

--

1,013,085 (558,664-1,240,295)

--

--